Ann: Prospectus, page-8

Yes the 20c CR was both under-subscribed and SP and below the CR. I fear nothing short of substantive orders is going to lift this stock. A major concern is past presentations have heavily promoted the premium quality of the product and hence a higher market valuation than its competitors. Given the company's financial predicament will they be able to hold fast to that or will we see an equal dilution there as well. If its the latter I fear it becomes purely an ethical investment vs capital growth investment.

For holders and new CR subscribers I anticipate the entire future will be determined in the "prospective sales pipeline" and the ability to follow through on the premium unit costs. DYOR regarding management's ability can capability to delivery against targets.